Lv2
110 积分 2024-09-26 加入
PA21: a novel phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease
3个月前
已完结
The Need for Novel Therapeutic Directions in Autosomal Dominant Polycystic Kidney Disease Patient Care
3个月前
已关闭
Effects of rhEPO-Fc on chronic renal anemia in Chinese patients undergoing maintenance hemodialysis: a multicenter, randomized, open-label, and phase 3 study
4个月前
已关闭
皖公网安备34019202002308
